Clinical Trial Update: Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating Gefitinib for patients with locally advanced or recurrent squamous cell skin cancer undergoing surgery and/or radiation therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer
• Squamous Cell Carcinoma of the Skin

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin | Phase 2 | Status: COMPLETED | Results posted: 2014-12-24